{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:00:05Z","timestamp":1789560005589,"version":"build-2803163510"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/ftd.0b013e3181c01da1","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T16:41:58Z","timestamp":1507912918000},"page":"743-745","source":"Crossref","is-referenced-by-count":33,"title":["Rheumatoid Factor Interference in a Tacrolimus Immunoassay"],"prefix":"10.1097","volume":"31","author":[{"given":"Bernard\u00ed Barcel\u00f3","family":"Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Maria","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartomeu Castanyer","family":"Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia Barcelo","family":"Bennasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Riesco","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina Fortuny","family":"Marqu\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210129","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007691-200202000-00011","article-title":"International Federation of Clinical Chemistry\/International Association of Therapeutic Drug Monitoring and Clinical Toxicology working group on immunosuppressive drug monitoring.","volume":"24","author":"Holt","year":"2002","journal-title":"Ther Drug Monit"},{"key":"R2-11-20210129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00003495-200565070-00005","article-title":"Tacrolimus: in patients with rheumatoid arthritis.","volume":"65","author":"Curran","year":"2005","journal-title":"Drugs"},{"key":"R3-11-20210129","first-page":"1258","article-title":"Falsely elevated cardiac troponin-I in patients with seropositive rheumatoid arthritis.","volume":"32","author":"Kenny","year":"2005","journal-title":"J Rheumatol"},{"key":"R4-11-20210129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1515\/CCLM.2006.205","article-title":"Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9).","volume":"44","author":"Berth","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"R5-11-20210129","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/ard.2007.070052","article-title":"Rheumatoid arthritis: correlation between rheumatoid factor levels and CA-125 tumour marker elevation.","volume":"66","author":"Tsavaris","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R6-11-20210129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0009-8981(03)00136-0","article-title":"Rheumatoid factor and false positive sex-hormone binding globulin.","volume":"332","author":"Lewis","year":"2003","journal-title":"Clin Chim Acta"},{"key":"R7-11-20210129","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0009-9120(99)00044-2","article-title":"High percentage of false positive cardiac troponin I results in patients with rheumatoid factor.","volume":"32","author":"Krahn","year":"1999","journal-title":"Clin Biochem"},{"key":"R8-11-20210129","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0091270007303765","article-title":"Analysis of factors influencing tacrolimus levels and immunoassay bias in renal transplantation.","volume":"47","author":"Borrows","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"R9-11-20210129","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/FTD.0b013e31819c6d5c","article-title":"Falsely increased blood tacrolimus concentration using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtain reliable results.","volume":"31","author":"Hermida","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R10-11-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/FTD.0b013e31819a7c19","article-title":"Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension.","volume":"31","author":"Barau","year":"2009","journal-title":"Ther Drug Monit"},{"key":"R11-11-20210129","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/clinchem\/45.5.616","article-title":"When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen.","volume":"45","author":"Kaplan","year":"1999","journal-title":"Clin Chem"},{"key":"R12-11-20210129","first-page":"4520","article-title":"Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors.","volume":"47","author":"Courtenay-Luck","year":"1987","journal-title":"Cancer Res"},{"key":"R13-11-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0090-1229(91)90084-N","article-title":"Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.","volume":"59","author":"Horneff","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"R14-11-20210129","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/clinchem\/43.6.957","article-title":"Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor.","volume":"43","author":"Norden","year":"1997","journal-title":"Clin Chem"},{"key":"R15-11-20210129","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10067-008-0931-z","article-title":"Safety profile of tacrolimus in patients with rheumatoid arthritis.","volume":"27","author":"Akimoto","year":"2008","journal-title":"Clin Rheumatol"},{"key":"R16-11-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/clinchem\/46.2.307","article-title":"Effect of rheumatoid factor on cardiac troponin I measurement using two commercial measurement systems.","volume":"46","author":"Onuska","year":"2000","journal-title":"Clin Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e3181c01da1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:37:17Z","timestamp":1620952637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-200912000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e3181c01da1","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}